type here...

CATEGORIES

Discover Drugs

LATEST

123Page 1 of 3

TRENDING

EDITORS CHOICE

Real-World Repercussions of Mislabeling Treatments as Vaccines

Robert Turner, Founding Editor -
Vaccinate, inoculate and immunize are three words that describe the "jab" people get to guard them against serious infectious illnesses. Harmonious - yes - but each offers a different consumer expectation.

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

How COVID and the Power of Now Killed Scientific Peer Review

Gil Bashe, Medika Life Editor -
How long do or should clinical trials take – well, it depends – but often years. Science takes time. It demands rigor and objectivity. It’s not a “now” pursuit.

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories